Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Cryoport, Inc.Financial_Report.xls
10-Q - FORM 10-Q - Cryoport, Inc.d399045d10q.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R33.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R32.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R29.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R19.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R22.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R25.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R24.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R30.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R18.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R23.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R28.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R31.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R13.htm
EX-3.1 - EX-3.1 - Cryoport, Inc.d399045dex31.htm
EX-32.1 - EX-32.1 - Cryoport, Inc.d399045dex321.htm
EX-31.1 - EX-31.1 - Cryoport, Inc.d399045dex311.htm
EX-31.2 - EX-31.2 - Cryoport, Inc.d399045dex312.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R21.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R20.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R27.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R26.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - Cryoport, Inc.R16.htm
v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
6 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Operating Activities    
Net loss $ (3,098,511) $ (4,083,964)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 216,931 162,051
Amortization of debt discount 8,843 127,930
Fair value of stock options and warrants issued to consultants, employees and directors 249,026 370,540
Change in fair value of derivative instruments (33,824) (48,968)
Loss on disposal of Cryogenic shippers 6,382   
Interest accrued on restricted cash    (274)
Changes in operating assets and liabilities:    
Accounts receivable (24,244) (55,593)
Inventories (4,165) 1,545
Other current assets 27,340 125,341
Accounts payable and accrued expenses 78,300 178,750
Accrued compensation and related expenses (91,208) 6,948
Accrued interest 9,261 24,380
Net cash used in operating activities (2,655,869) (3,191,314)
Investing Activities    
Purchases of intangible assets    (79,547)
Purchases of property and equipment (46,779) (122,806)
Net cash used in investing activities (46,779) (202,353)
Financing Activities    
Repayments of convertible debentures payable (82,800) (1,176,628)
Payment of deferred financing costs (122,453) (158,270)
Proceeds from exercise of warrants    456,133
Repayments of related party notes payable (40,000) (54,000)
Payment on line of credit    (90,000)
Proceeds from release of restricted cash    91,443
Net cash used in financing activities (245,253) (931,322)
Net change in cash and cash equivalents (2,947,901) (4,324,989)
Cash and cash equivalents, beginning of period 4,617,535 9,278,443
Cash and cash equivalents, end of period 1,669,634 4,953,454
Cash paid during the period for:    
Interest 15,676 88,758
Income taxes 1,600 1,600
SUPPLEMENTAL DISCLOSURE OF NON-CASH ACTIVITIES:    
Offering costs in connection with equity financing included in accounts payable 59,569   
Cashless exercise of warrants    36
Release of restricted cash for repayment of convertible debentures payable $ 251,368